Brief: Astrazeneca Pharma India Dec-Quarter PAT Falls
Feb 8 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA DEC-QUARTER PAT 210.5 MILLION
RUPEES
VERSUS PROFIT 267 MILLION RUPEES YEAR AGO
* ASTRAZENECA PHARMA INDIA DEC-QUARTER REVENUE FROM
OPERATIONS 2
BILLION RUPEES VERSUS 2.24 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE8F6G4H
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan